Immunosuppressive therapy for myocarditis

Robert E. Cunnion, Joseph E. Parrillo, Bernhard Maisch, Fulvio Camerini, Heinz Peter Schultheiss, Leslie T. Cooper, Ralph Shabetai, Jay W. Mason, John B. O'connell, Bruce M. Mcmanus

Research output: Contribution to journalLetter

28 Scopus citations

Abstract

To the Editor: Mason and colleagues report the results of a clinical trial of immunosuppressive therapy for myocarditis (Aug. 3 issue).1 Ventricular function improved to the same extent among the patients randomly assigned to receive conventional therapy plus immunosuppressive treatment as among those who received conventional therapy alone. McKenna and Davies, in an accompanying editorial, observe that many patients with dilated cardiomyopathy have immunohistochemical evidence of inflammation, even though they may not meet the Dallas criteria for the histologic diagnosis of myocarditis, and the authors allude to the question of a potential role for immunosuppression in the treatment of dilated.

Original languageEnglish (US)
Pages (from-to)1713-1714
Number of pages2
JournalNew England Journal of Medicine
Volume333
Issue number25
DOIs
StatePublished - Dec 21 1995
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunosuppressive therapy for myocarditis'. Together they form a unique fingerprint.

  • Cite this

    Cunnion, R. E., Parrillo, J. E., Maisch, B., Camerini, F., Schultheiss, H. P., Cooper, L. T., Shabetai, R., Mason, J. W., O'connell, J. B., & Mcmanus, B. M. (1995). Immunosuppressive therapy for myocarditis. New England Journal of Medicine, 333(25), 1713-1714. https://doi.org/10.1056/NEJM199512213332513